Transdermal Drug Delivery Resources

1. 3D Screen Printing: Enabling A New Generation Of Complex Formulations 3/17/2025

   Screen-Printed Innovative Drug Technology can produce oral, transdermal, and implantable dosage forms while ensuring heterogeneous distribution of active ingredients.

2. Contract Design And Development Vs. In-House: How To Find The Best Fit 3/21/2024

   Explore the rationale behind opting for a contract development organization (CDO) to fulfill organizational requirements and underscore vital considerations for evaluating CDOs to ensure alignment with your project objectives.

3. Combining Gene Therapies, Carrier Systems, And Medical Devices 3/23/2023

   Drug delivery is one of the most significant obstacles to advancing gene therapies. Examine the opportunities for success in combining novel medical devices to improve delivery of gene therapies.

4. Solubility With Lipid-Based Technologies For Oral & Injectable Formulations 11/7/2022

   Innovative approaches in developing formulations can help to improve a drug's safety and efficacy. Explore the decision for selecting the best-suited technology for formulating a complex molecule.

5. Microphysiological Systems: Closing The Gap Between Models And Medicine 9/2/2025

   Microphysiological systems (MPS) use human cells to model tissue function, offering faster, more predictive insights for drug discovery, safety testing, and personalized medicine—bridging gaps left by animal and 2D models.

6. Drug Formulation Development: Quick Reference Guide 7/11/2022

   This guide shares the steps involved in formulation development, considerations during formulation, and how partnering with an experienced CDMO can lead to a successful commercial product.

7. Is Your Combination Product Drug-Led Or Device-Led? 11/30/2022

   The $118 billion combination-product market is projected to increase at a CAGR of 8.8%. This article answers the question: “Is this actually a combination product? What do we need to do if it is?”

8. 4 Opportunities For Advancing Drug Delivery 2/3/2026

   In this article, Fran DeGrazio identifies four prime opportunities for drug delivery developers to move the dial of innovation into 2026 and beyond. These avenues for advancement include diagnostics, patient tolerability, microdosing, and analytical methodologies. 

9. Wet Milling Vs. Dry Milling In The Pharmaceutical Industry 8/10/2022

   Read about the considerations necessary for choosing between wet milling and dry milling for a specific active pharmaceutical ingredient.

10. Formulation Development From Preclinical To First-In-Human 1/24/2022

    A compound with poor biopharmaceutical properties or improper formulation design could lead to a delay in the project or even program termination.